MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Omiecinski, C. J.
Right arrow Articles by Costa, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Omiecinski, C. J.
Right arrow Articles by Costa, P.

Developmental expression and in situ localization of the phenobarbital- inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6, and CYP3A1

CJ Omiecinski, C Hassett and P Costa

Department of Environmental Health, University of Washington, Seattle 98195.

In this study we examined the differential hepatic expression of four phenobarbital (PB)-inducible rat cytochrome P450 genes, CYP2B1, CYP2B2, CYP2C6, and CYP3A1. The mRNAs encoding these cytochromes were analyzed in the liver with respect to PB responsiveness, developmental expression, and in situ localization. Utilization of the polymerase chain reaction enabled assessment of specific hepatic mRNA expression patterns during early development that were not detectable with standard Northern blot or slot-blot procedures. The polymerase chain reaction data demonstrated that fetal liver from day 15 of gestation was responsive to the inductive effects of transplacental PB administration. Both constitutive and PB-induced levels of each mRNA increased with increasing developmental age, reaching maximal levels approximately 3 weeks postpartum. An exception to this trend was observed for rats of gestational day 22, which exhibited transiently increased constitutive levels of CYP2B1, CYP2B2, and CYP3A1 mRNAs, such that PB-induced levels were not elevated over those observed in untreated animals. In situ hybridization data, obtained with livers form 6-week postpartum animals, revealed striking differences in regional distributions among the cytochrome P450 transcripts. Whereas patterns of PB-induced expression of CYP2C6 mRNAs were relatively homogeneous across the hepatic lobule, CYP3A1 mRNAs in PB-treated livers demonstrated marked centrilobular localization. These results were in contrast to data obtained previously for PB-inducible CYP2B1 and CYP2B2 mRNAs, which were distributed homogeneously across the hepatic lobule except for cells in the immediate vicinity of the periportal tract.

Volume 38, Issue 4, pp. 462-470, 10/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Toxicol SciHome page
A. Johri, A. Dhawan, R. L. Singh, and D. Parmar
Persistence in Alterations in the Ontogeny of Cerebral and Hepatic Cytochrome P450s following Prenatal Exposure to Low Doses of Lindane
Toxicol. Sci., February 1, 2008; 101(2): 331 - 340.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. B. Dail, S. C. Burgess, E. C. Meek, J. Wagner, J. Baravik, and J. E. Chambers
Spatial Distribution of CYP2B1/2 Messenger RNA within the Rat Liver Acinus following Exposure to the Inducers Phenobarbital and Dieldrin
Toxicol. Sci., September 1, 2007; 99(1): 35 - 42.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. I. Couroucli, Y. W. Liang, W. Jiang, R. Barrios, and B. Moorthy
Attenuation of Oxygen-Induced Abnormal Lung Maturation in Rats by Retinoic Acid: Possible Role of Cytochrome P4501A Enzymes
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 946 - 954.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. R. Sharma, P. Periandythevar, and B. H. Shapiro
SPURIOUS OBSERVATION OF SPLENIC CYP2B1 EXPRESSION
Drug Metab. Dispos., September 1, 2003; 31(9): 1074 - 1076.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Degawa, M. Namiki, N. Yoshimoto, M. Makino, M. Iwamoto, K. Nemoto, and Y. Hashimoto
Constitutive Expression of Cytochrome P450 Genes in Newly Established Rat Hepatic Cell Lines
J. Biochem., June 1, 2003; 133(6): 825 - 831.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. T. Stott, K. A. Johnson, R. Bahnemann, S. J. Day, and R. J. McGuirk
Evaluation of Potential Modes of Action of Inhaled Ethylbenzene in Rats and Mice
Toxicol. Sci., January 1, 2003; 71(1): 53 - 66.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. A. C. 't Hoen, M. K. Bijsterbosch, T. J. C. van Berkel, N. P. E. Vermeulen, and J. N. M. Commandeur
Midazolam Is a Phenobarbital-Like Cytochrome P450 Inducer in Rats
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 921 - 927.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Schilter, M. R. Andersen, C. Acharya, and C. J. Omiecinski
Activation of Cytochrome P450 Gene Expression in the Rat Brain by Phenobarbital-Like Inducers
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 916 - 922.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
G. J. Gordon, W. B. Coleman, and J. W. Grisham
Temporal Analysis of Hepatocyte Differentiation by Small Hepatocyte-Like Progenitor Cells during Liver Regeneration in Retrorsine-Exposed Rats
Am. J. Pathol., September 1, 2000; 157(3): 771 - 786.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. K. Agrawal and B. H. Shapiro
Latent Overexpression of Hepatic CYP2C7 in Adult Male and Female Rats Neonatally Exposed to Phenobarbital: A Developmental Profile of Gender-Dependent P450s
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1027 - 1033.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
D. W. Singleton, X.-D. Lei, S. J. Webb, R. A. Prough, and T. E. Geoghegan
Cytochrome P-450 mRNAs Are Modulated by Dehydroepiandrosterone, Nafenopin, and Triiodothyronine
Drug Metab. Dispos., February 1, 1999; 27(2): 193 - 200.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Gupta, P. Rajvanshi, R. P. Sokhi, S. Vaidya, A. N. Irani, and G. R. Gorla
Position-specific Gene Expression in the Liver Lobule Is Directed by the Microenvironment and Not by the Previous Cell Differentiation State
J. Biol. Chem., January 22, 1999; 274(4): 2157 - 2165.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
K. Mino, J. Watanabe, and S. Kanamura
Effect of 3-Methylcholanthrene Administration on Expression of Cytochrome P-450 Isoforms Induced by Phenobarbital in Rat Hepatocytes
J. Histochem. Cytochem., October 1, 1998; 46(10): 1151 - 1160.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. S. Sidhu and C. J. Omiecinski
An Okadaic Acid-Sensitive Pathway Involved in the Phenobarbital-Mediated Induction of CYP2B Gene Expression in Primary Rat Hepatocyte Cultures
J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 1122 - 1129.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. S. Sidhu and C. J. Omiecinski
cAMP-associated Inhibition of Phenobarbital-inducible Cytochrome P450 Gene Expression in Primary Rat Hepatocyte Cultures
J. Biol. Chem., May 26, 1995; 270(21): 12762 - 12773.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics